Table I.
Drug Susceptibility for Clinical Isolates
| Nisoa | Nstructb | Three classes
|
Two classes
|
||||
|---|---|---|---|---|---|---|---|
| Susc (%) | Low/int (%) | High (%) | Low (%) | High (%) | |||
| Amprenavir (APV) | 768 | 2327 | 68 | 21 | 11 | 83 | 17 |
| Atazanavir (ATV) | 329 | 796 | 35 | 29 | 36 | 55 | 45 |
| Indinavir (IDV) | 827 | 2444 | 54 | 31 | 15 | 68 | 32 |
| Lopinavir (LPV) | 517 | 1611 | 43 | 26 | 31 | 62 | 38 |
| Nelfinavir (NFV) | 844 | 2464 | 47 | 19 | 34 | 57 | 43 |
| Ritonavir (RTV) | 795 | 2407 | 51 | 17 | 32 | 65 | 35 |
| Saquinavir (SQV) | 826 | 2445 | 62 | 18 | 20 | 73 | 27 |
a
Niso is the number of clinical isolates.
b
Nstruct is the number of structures, which includes all possible combinations of mutations in each isolate.